The resources and modeling advances supporting AI virtual cells' value for mechanism-of-action analysis, efficacy, safety, resistance, and combination studies are reviewed, and evidence requirements for pharmacological use are defined.
Shi-Hang Wang, Yang Zhang, Dong Wang et al.· TIPS - Trends in Pharmacolog...· 0 citations
The structure-based covalent modifications that generate new nonpeptidic covalent Mpro inhibitors are described that may support the deuterated compound as a new lead for developing anti-SARS-CoV-2 drugs and further reveal the feasibility of using chloroacetyl for structure-based covalent drug design.
Honglei Bao, Ling-Chen Sun, Shi-Lin Gong et al.· ACS Bio & Med Chem Au· 0 citations
TPS-Flow is presented, a physics-guided flow-based generative framework for end point-conditioned conformational path sampling between predefined protein states (not equilibrium ensembles), thereby bridging atomistic simulation and deep generative modeling of protein transition paths.
Kai Xu, Likun Zhao, Yanan Tian et al.· Journal of Chemical Informat...· 0 citations
An integrated virtual screening strategy based on molecular fingerprint similarity, pharmacophore models, molecular docking, and molecular dynamics simulation is proposed and three promising lead compounds targeting RIPK3 for AD treatment are offered.
Cheng-Gong Fu, Qin Li, Yu-Wei Yang et al.· Molecular diversity· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.